Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KTTA

Pasithea Therapeutics Corp

May 27 • 04:00PM ET

0.6929

+0.0128 1.88 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BCTX CLRB JSPR LGVN MRKR NXTC PLUR TPST TRAW VTGN

| Held by: PSIL VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.07	Insider Own	11.37%	Shs Outstand	33.41M	Perf Week	-1.38%
Market Cap	23.15M	Forward P/E	-	EPS next Y	-1.01	Insider Trans	5.56%	Shs Float	29.62M	Perf Month	0.42%
Enterprise Value	-27.35M	PEG	-	EPS next Q	-0.12	Inst Own	52.61%	Short Float	1.00%	Perf Quarter	-18.64%
Income	-19.73M	P/S	-	EPS this Y	73.88%	Inst Trans	-2.52%	Short Ratio	0.70	Perf Half Y	137.05%
Sales	0.00M	P/B	0.32	EPS next Y	-32.89%	ROA	-55.58%	Short Interest	0.30M	Perf YTD	-46.29%
Book/sh	2.20	P/C	0.46	EPS next 5Y	23.55%	ROE	-58.22%	52W High	2.06 -66.36%	Perf Year	-23.86%
Cash/sh	1.51	P/FCF	-	EPS past 3/5Y	35.92% -117.71%	ROIC	-36.00%	52W Low	0.28 146.58%	Perf 3Y	-90.88%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.26% 7.13%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	80.42%	Oper. Margin	-	ATR (14)	0.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	35.40	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	39.28	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	35.40	EPS Q/Q	92.68%	SMA20	-9.57%	Beta	0.23	Target Price	3.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-8.33%	Rel Volume	0.34	Prev Close	0.68
Employees	5	LT Debt/Eq	0.00	Earnings	Feb 25	SMA200	-15.16%	Avg Volume	422.32K	Price	0.69
IPO	Sep 15, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-338.89% -	Trades		Volume	144,299	Change	1.88%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)